IP Library › Granted Patent US 12,435,349
Granted Patent B2
US 12,435,349 · App. 18/569,989 · Granted Oct 7, 2025

Enzymatic method for the production of l-glufosinate p-alkyl esters

Inventors: Ludger Lautenschütz (Hanau, DE); Steffen Oßwald (Nidderau, DE); Markus Pötter (Muenster, DE); Jakob Müller (Haltern am See, DE)
Assignee: Evonik Operations GmbH
C12P13/04C12N9/80C12N9/90C12Y305/01087C12Y305/02002C12Y501/99005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,435,349
App. No.
18/569,989
Granted
Oct 7, 2025
Kind
B2
Abstract

An enzymatic method for the production of an L-glufosinate P-alkyl ester can be performed. This method is characterized by reacting an L-glufosinate P-alkyl ester carbamoylate to give the corresponding L-glufosinate P-alkyl ester. This is catalyzed by a carbamoylase. The L-glufosinate P-alkyl ester carbamoylate employed may be obtained by a reaction from the corresponding L-glufosinate hydantoin P-alkyl ester. This is catalyzed by a hydantoinase, preferably an L-enantioselective hydantoinase. In a second aspect, an enzymatic method for enantioselective production of an L-glufosinate P-alkyl ester from a mixture M IIIA of L- and D-glufosinate P-alkyl ester hydantoins can be performed. The L-glufosinate P-alkyl ester obtained in the methods according to the first or second aspect of the invention may be saponified to give L-glufosinate.

Claims (36)

1. A method for the production of an L-glufosinate P-alkyl ester according to formula L-(I), the method comprising:

reacting a compound according to formula L-(II) to give a compound according to formula L-(I):

wherein the reacting comprises hydrolyzing L-(II) to give L-(I); wherein the hydrolyzing of L-(II) to give L-(1) is catalyzed by an L-carbamoylase,

wherein R is an alkyl group or an aryl group; and

wherein the polypeptide sequence of the L-carbamoylase is selected from the group consisting of SEQ ID NO: 1 and variants thereof, SEQ ID NO: 2 and variants thereof, SEQ ID NO: 3 and variants thereof, SEQ ID NO: 4 and variants thereof, SEQ ID NO: 5 and variants thereof, SEQ ID NO: 6 and variants thereof, SEQ ID NO: 7 and variants thereof, SEQ ID NO: 8 and variants thereof, and SEQ ID NO:9 and variants thereof,

wherein the variants have at least 90% sequence identity to the referenced polypeptide sequence.

2. The method according to claim 1 , wherein R is an alkyl group.

3. The method according to claim 1 , wherein the L-carbamoylase is categorized in the EC class 3.5.1.87.

4. The method according to claim 1 , wherein the compound according to formula L-(II) is obtained by reacting a compound according to formula L-(III) to give a compound according to formula L-(II):

wherein the reaction of L-(III) to give L-(II) is catalyzed by a hydantoinase, and wherein R has the same meaning as described for L-(I).

5. The method according to claim 4 , wherein the hydantoinase is categorized in the EC class 3.5.2.2.

6. The method according to claim 4 , wherein a polypeptide sequence of the hydantoinase is selected from the group consisting of SEQ ID NO: 10 and variants thereof, SEQ ID NO: 11 and variants thereof, SEQ ID NO: 12 and variants thereof, SEQ ID NO: 13 and variants thereof, SEQ ID NO: 14 and variants thereof, SEQ ID NO: 15 and variants thereof, and SEQ ID NO: 16 and variants thereof.

7. The method according to claim 4 , wherein the hydantoinase is an L-hydantoinase.

8. The method according to claim 4 , wherein the compound according to formula L-(III) is obtained by reacting a compound according to formula D-(III) to give a compound according to formula L-(III):

and wherein R has the same meaning as described for L-(I).

9. The method according to claim 8 , wherein the reaction of D-(III) to give L-(III) is catalyzed by a hydantoin racemase.

10. The method according to claim 9 , wherein the hydantoin racemase is categorized in the EC class 5.1.99.5.

11. The method according to claim 9 , wherein the polypeptide sequence of the hydantoin racemase is selected from the group consisting of SEQ ID NO: 17 and variants thereof, SEQ ID NO: 18 and variants thereof, SEQ ID NO: 19 and variants thereof, SEQ ID NO: 20 and variants thereof, SEQ ID NO: 21 and variants thereof, SEQ ID NO: 22 and variants thereof, SEQ ID NO: 23 and variants thereof, SEQ ID NO: 24 and variants thereof, SEQ ID NO: 25 and variants thereof, and SEQ ID NO: 26 and variants thereof.

12. A method for the production of an L-glufosinate P-alkyl ester according to formula L-(I), wherein R is an alkyl group or aryl group:

the method comprising:

(i-A) providing a mixture MIA comprising both enantiomers L-(III) and D-(III),

wherein R has the same meaning as described for L-(I):

(i-B) optionally reacting at least a part of the compounds D-(III) comprised by the mixture MIA into L-(III), giving a composition Mus comprising L-(III) and optionally its enantiomer D-(III);

(ii) subjecting mixture MINIA or, in case (i-B) is carried out, composition Mma, to a reaction where a compound according to formula L-(III) is reacted to give a compound according to formula L-(II), giving a composition Mu comprising L-(II) and optionally its enantiomer D-(II), wherein L-(II) and D-(II) have the following formulae and wherein R in formulae L-(II) and D-(II) has the same meaning as described for L-(I):

(iii) subjecting Mn to a reaction where a compound according to formula L-(II) is reacted to give a compound according to formula L-(I), giving a composition Ma comprising L-(I) and optionally its enantiomer D-(I), wherein, in case Mi comprises both enantiomers L-(I) and D-(I), a molar ratio of L-(I) to D-(I) in Mr is greater than a molar ratio of L-(III) to D-(III) in MIA, wherein D-(I) has the following formula and wherein R in formula D-(I) has the same meaning as described for L-(I):

wherein the reacting of L-(II) to give L-(1) is catalyzed by an L-carbamoylase

wherein the polypeptide sequence of the L-carbamoylase is selected from the group consisting of SEQ ID NO: 1 and variants thereof, SEQ ID NO: 2 and variants thereof, SEQ ID NO: 3 and variants thereof, SEQ ID NO: 4 and variants thereof, SEQ ID NO: 5 and variants thereof, SEQ ID NO: 6 and variants thereof, SEQ ID NO: 7 and variants thereof, SEQ ID NO: 8 and variants thereof, and SEQ ID NO: 9 and variants thereof

wherein the variants have at least 90% sequence identity to the referenced polypeptide sequence.

13. The method according to claim 1 , wherein the compound according to formula L-(I) is saponified to give L-glufosinate.

14. The method according to claim 12 , wherein the compound according to formula L-(I) is saponified to give L-glufosinate.

15. The method according to claim 1 , wherein the polypeptide sequence of the L-carbamoylase has at least 60% sequence identity to SEQ ID NO: 1.

16. The method according to claim 1 , wherein the polypeptide sequence of the L-carbamoylase is selected from the group consisting of SEQ ID NO.s: 1, 2, 3, 5, and 8, and variants thereof.

17. The method according to claim 1 , wherein the polypeptide sequence of the L-carbamoylase is selected from the group consisting of SEQ ID NO.s: 1, 2, 3, 5, and 8.

18. The method according to claim 16 , wherein the variants have at least 95% identity to the referenced polypeptide sequence.

19. The method according to claim 6 ,

wherein the hydantoinase variants have at least 80% sequence identity to the referenced polypeptide sequence.

Priority Claims (1)
EP 21179773 · Jun 16, 2021 · regional
Continuity (1)
Related Publication 20240287558A1 · Aug 29, 2024
References Cited (99)
US 5442088A · Hoffmann · 1995 [cited by applicant]
US 6359162B1 · Willms · 2002 [cited by applicant]
US 6524837B1 · Arnold et al. · 2003 [cited by applicant]
US 7217544B2 · Hummel et al. · 2007 [cited by applicant]
US 7288402B2 · Osswald et al. · 2007 [cited by applicant]
US 7491521B2 · Osswald et al. · 2009 [cited by applicant]
US 7592165B2 · Osswald et al. · 2009 [cited by applicant]
US 7943359B2 · Osswald et al. · 2011 [cited by applicant]
US 9765370B2 · Hennemann et al. · 2017 [cited by applicant]
US 9957536B2 · Osswald et al. · 2018 [cited by applicant]
US 10822627B2 · Osswald et al. · 2020 [cited by applicant]
US 20030175910A1 · Allenbuchner et al. · 2003 [cited by applicant]
US 20050214912A1 · Nozaki et al. · 2005 [cited by applicant]
US 20060063238A1 · Hummel et al. · 2006 [cited by applicant]
US 20060068467A1 · Osswald et al. · 2006 [cited by applicant]
US 20060210989A1 · May et al. · 2006 [cited by applicant]
US 20060228787A1 · May et al. · 2006 [cited by applicant]
US 20070128689A1 · May et al. · 2007 [cited by applicant]
US 20080057549A1 · Osswald et al. · 2008 [cited by applicant]
US 20080102496A1 · Verseck et al. · 2008 [cited by applicant]
US 20080248538A1 · Osswald et al. · 2008 [cited by applicant]
US 20100021977A1 · May et al. · 2010 [cited by applicant]
US 20100143981A1 · Rusnak-Müller et al. · 2010 [cited by applicant]
US 20100261250A1 · Osswald et al. · 2010 [cited by applicant]
US 20140308717A1 · Haas et al. · 2014 [cited by applicant]
US 20150056667A1 · Osswald et al. · 2015 [cited by applicant]
US 20150111254A1 · Hennemann et al. · 2015 [cited by applicant]
US 20170253897A1 · Green et al. · 2017 [cited by applicant]
US 20180237814A1 · Osswald et al. · 2018 [cited by applicant]
US 20200181179A1 · Fields et al. · 2020 [cited by applicant]
US 20210214754A1 · Green et al. · 2021 [cited by applicant]
US 20220024955A1 · Jeon et al. · 2022 [cited by applicant]
US 20220194896A1 · Lautenschuetz et al. · 2022 [cited by applicant]
US 20220306658A1 · Jeon et al. · 2022 [cited by applicant]
CN 106083922 · 2016 [cited by applicant]
CN 108516991 · 2018 [cited by applicant]
CN 111662325 · 2020 [cited by applicant]
DE 3142036 · 1983 [cited by applicant]
EP 0508296 · 1992 [cited by applicant]
EP 1829975 · 2007 [cited by applicant]
EP 4151643 · 2023 [cited by applicant]
WO 9909039 · 1999 [cited by applicant]
WO 0058449 · 2000 [cited by applicant]
WO 0123582 · 2001 [cited by applicant]
WO 2005090577 · 2005 [cited by applicant]
WO 2008067981 · 2008 [cited by applicant]
WO 2013072486 · 2013 [cited by applicant]
WO 2014067746 · 2014 [cited by applicant]
WO 2017151573 · 2017 [cited by applicant]
WO 2019018406 · 2019 [cited by applicant]
WO 2020051188 · 2020 [cited by applicant]
WO 2020145513 · 2020 [cited by applicant]
WO 2020145514 · 2020 [cited by applicant]
WO 2020145627 · 2020 [cited by applicant]
WO 2022207543 · 2022 [cited by applicant]
WO 2023174511 · 2023 [cited by applicant]
WO 2023222226 · 2023 [cited by applicant]
WO 2023222227 · 2023 [cited by applicant]
WO 2023232225 · 2023 [cited by applicant]
WO 2024061455 · 2024 [cited by applicant]
WO 2024061456 · 2024 [cited by applicant]
Franceus et al. J. Ind. Microbiol. Biotechnol. vol. 44, pp. 687-695, 2017. [cited by examiner]
Ngo et al. in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz et al. (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495. [cited by examiner]
Martinez-Rodriguez et al., Applied Microbiol Biotechnol, vol. 85, pp. 441-458, 2010. [cited by examiner]
Bovarnick et al., “Racemization of Tripeptides and Hydantoins”, Contribution from the Department of Biological Chemistry, Journal of the American Society, vol. 60, Oct. 1938, pp. 2426-2430. [cited by applicant]
A.S. Bommarius et al., “A direct route from hydantoins to D-amino acids employing a resting cell biocatalyst with D-hydantoinase and D-carbamoylase activity” on p. 164 and 167 in Microbial reagents in Organic Synthesis … [cited by applicant]
Clemente-Jiménez et al., “Optically Pure α-Amino Acids Production by the Hydantoinase Process”, Recent Patents on Biotechnology, vol. 2, 2008, pp. 35-46. [cited by applicant]
Elinor Ware, “The Chemistry of the Hydantoins”, Department of Chemistry, Hood College, Frederick, Maryland, Chem. Rev., 1950, pp. 403-470. [cited by applicant]
Engel et al., “The Hydantoinase Process: Recent Developments for the Production of Non-Canonical Amino Acids”, Industrial Biocatalysis, Chapter 22, Edited by P. Grunwald, Pan Stanford Publishing, 2015, pp. 817-862. [cited by applicant]
Gerhard Hoerlein, “Glufosinate (Phosphinothricin), A Natural Amino Acid with Unexpected Herbicidal Properties”, Glufosinate Herbicide, Reviews of Environmental Contamination and Toxicology, vol. 73, 1994, pp. 73-145. [cited by applicant]
Heras-Vázquez et al., “Hydantoin Racemase: the Key Enzyme for the Production of Optically Pure α-Amino Acids”, Modern Biocatalysis: Stereoselective and Environmentally Friendly Reactions, Edited by Wolf-Dieter Fessner a… [cited by applicant]
International Search Report received for PCT Application No. PCT/EP2022/064682, mailed on Oct. 27, 2022, 7 pages. [cited by applicant]
Karl-Josef Haack, “Synthese-Entwicklung unter speziellen Randbedingungen [Synthesis development under special boundary conditions]”, Chem. Unserer Zeit, vol. 37, 2003, pp. 128-138, with English translation of pp. 128-13… [cited by applicant]
Avendaño et al., Review, “Hydantoin and Its Derivatives”, Kirk-Othmer Encyclopedia of Chemical Technology, 2000, pp. 1-21. [cited by applicant]
Latacz et al., “Hydantoinazy, ich znaczenie, podziat i zastosowanie w biotechnologii [Hydantoinases and their role, classification and use in biotechnology]”, Biotechnologia, vol. 2, No. 73, 2006, pp. 189-205 with Engli… [cited by applicant]
Martínez-Rodríguez et al., “Overview on Multienzymatic Cascades for the Production of Non-canonical α-Amino Acids”, Frontiers in Bioengineering and Biotechnology, vol. 8, Aug. 2020, pp. 1-36. [cited by applicant]
May et al., “Development of Dynamic Kinetic Resolution Processes for Biocatalytic Production of Natural and Nonnatural [cited by applicant]
Ogawa et al., “Purification and Characterization of N-carbamoyl-L-Amino Acid Amidohydrolase with Broad Substrate Specificity from Alcaligenes Xylosoxidans”, Appl Microbiol. Biotechnol., vol. 43, 1995, pp. 1039-1043. [cited by applicant]
Robert A. Lazarus, “Chemical Racemization of 5-Benzylhydantoin”, J. Org. Chem., vol. 55, 1990, pp. 4755-4757. [cited by applicant]
Ruhland et al., “A comparative investigation of the metabolism of the herbicide glufosinate in cell cultures of transgenic glufosinate-resistant and non-transgenic oilseed rape ( [cited by applicant]
Slomka et al., “Chemical synthesis and enzymatic, stereoselective, hydrolysis of a functionalized dihydropyrimidine for the synthesis of β-amino acids”, AMB Expr, vol. 5, No. 85, 2015, pp. 1-8. [cited by applicant]
Thomas Waniek, “Untersuchungen zur Substratspezifität und Enantioselektivität mikrobieller Hydantoinasen [Substrate specificity studies and enantioselectivity of microbial hydantoinases]”, Institut für Bioverfahrenstech… [cited by applicant]
Wilms et al., “Cloning, nucleotide sequence and expression of a new [cited by applicant]
Written Opinion received for PCT Application No. PCT/EP2022/064682, mailed on Oct. 27, 2022, 9 pages. [cited by applicant]
Yokozeki et al., “Mechanism of Asymmetric Production of L-Aromantic Amino Acids from the Corresponding Hydantoins by [cited by applicant]
U.S. Pat. No. 7,217,544, May 15, 2007, 2006/0063238, Hummel et al. [cited by applicant]
U.S. Pat. No. 7,592,165, Sep. 22, 2009, 2008/0248538, Osswald et al. [cited by applicant]
U.S. Pat. No. 7,943,359, May 17, 2011, 2010/0261250, Osswald et al. [cited by applicant]
U.S. Appl. No. 10/593,362, filed Sep. 18, 2006, 2008/0102496, Verseck et al. [cited by applicant]
U.S. Pat. No. 7,288,402, Oct. 30, 2007, 2006/0068467, Osswald et al. [cited by applicant]
U.S. Pat. No. 7,491,521, Feb. 17, 2009, 2008/0057549, Osswald et al. [cited by applicant]
U.S. Appl. No. 12/441,145, filed Mar. 13, 2009, 2010/0021977, May et al. [cited by applicant]
U.S. Pat. No. 9,765,370, Sep. 19, 2017, 2015/0111254, Hennemann et al. [cited by applicant]
U.S. Appl. No. 14/237,121, filed Feb. 20, 2014, 2014/0308717, Haas et al. [cited by applicant]
U.S. Pat. No. 9,957,536, May 1, 2018, 2015/0056667, Osswald et al. [cited by applicant]
U.S. Pat. No. 10,822,627, Nov. 3, 2020, 2018/0237814, Osswald et al. [cited by applicant]
U.S. Appl. No. 61/721,445, filed Nov. 1, 2012, Osswald et al. [cited by applicant]
U.S. Appl. No. 17/425,907, filed Jul. 26, 2021, 2022/0194896, Lautenschuetz et al. [cited by applicant]
U.S. Appl. No. 18/553,072, filed Sep. 28, 2023, Pötler et al. [cited by applicant]